Avidity Biosciences Inc RNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
26.02UNCH (UNCH)
Volume
12,633
Close
26.02quote price arrow up+0.06 (+0.23%)
Volume
765,679
52 week range
4.82 - 27.66
Loading...
  • Open26.04
  • Day High26.70
  • Day Low25.68
  • Prev Close25.96
  • 52 Week High27.66
  • 52 Week High Date04/03/24
  • 52 Week Low4.82
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap2.488B
  • Shares Out95.62M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change187.51

KEY STATS

  • Open26.04
  • Day High26.70
  • Day Low25.68
  • Prev Close25.96
  • 52 Week High27.66
  • 52 Week High Date04/03/24
  • 52 Week Low4.82
  • 52 Week Low Date10/31/23
  • Market Cap2.488B
  • Shares Out95.62M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change187.51

RATIOS/PROFITABILITY

  • EPS (TTM)-2.95
  • P/E (TTM)-8.82
  • Fwd P/E (NTM)-8.22
  • EBITDA (TTM)-252.804M
  • ROE (TTM)-32.91%
  • Revenue (TTM)10.87M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,103.78%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Its advancing and expanding pipeline has three programs in clinical...
Troy Wilson J.D., Ph.D.
Chairman of the Board
Sarah Boyce
President, Chief Executive Officer, Director
Michael Maclean
Chief Financial and Chief Business Officer
W. Michael Flanagan Ph.D.
Chief Scientific and Technical Officer
Address
10578 SCIENCE CENTER DRIVE, SUITE 125
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
GERN
Geron Corp
3.74-0.06-1.58%
SANA
Sana Biotechnology Inc
7.91+0.35+4.63%
CLDX
Celldex Therapeutics Inc
40.11+0.19+0.48%
DYN
Dyne Therapeutics Inc
26.62+0.62+2.38%
MLTX
MoonLake Immunotherapeutics
41.71+0.79+1.93%